BBVA
BIIB icon

Banco Bilbao Vizcaya Argentaria’s Biogen BIIB Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.77M Sell
42,471
-104,480
-71% -$19.3M 0.05% 227
2025
Q4 		$25.9M Buy
146,951
+8,297
+6% +$1.36M 0.18% 94
2025
Q3 		$19.4M Buy
138,654
+23,782
+21% +$3.21M 0.15% 125
2025
Q2 		$14.4M Sell
114,872
-14,641
-11% -$1.82M 0.13% 145
2025
Q1 		$17.7M Buy
129,513
+2,231
+2% +$319K 0.18% 115
2024
Q4 		$19.4M Sell
127,282
-2,418
-2% -$408K 0.2% 99
2024
Q3 		$25.1M Buy
129,700
+19,692
+18% +$4.12M 0.25% 80
2024
Q2 		$25.5M Sell
110,008
-900
-0.8% -$196K 0.27% 81
2024
Q1 		$23.9M Sell
110,908
-3,992
-3% -$935K 0.27% 78
2023
Q4 		$29.7M Sell
114,900
-33,541
-23% -$8.24M 0.35% 65
2023
Q3 		$38.1M Sell
148,441
-1,020
-0.7% -$273K 0.51% 40
2023
Q2 		$42.6M Buy
149,461
+2,520
+2% +$750K 0.55% 32
2023
Q1 		$40.9M Buy
146,941
+7,893
+6% +$2.18M 0.51% 43
2022
Q4 		$38.5M Buy
139,048
+22,727
+20% +$6.42M 0.56% 34
2022
Q3 		$31.1M Sell
116,321
-18,734
-14% -$3.98M 0.5% 43
2022
Q2 		$27.6M Buy
135,055
+1,005
+0.7% +$205K 0.42% 59
2022
Q1 		$28.6M Buy
134,050
+13,319
+11% +$2.9M 0.39% 64
2021
Q4 		$28.7M Buy
120,731
+103,510
+601% +$26.6M 0.38% 51
2021
Q3 		$4.96M Buy
17,221
+4,610
+37% +$1.51M 0.08% 224
2021
Q2 		$3.95M Buy
12,611
+308
+3% +$93.3K 0.07% 253
2021
Q1 		$3.34M Sell
12,303
-4,340
-26% -$1.17M 0.07% 259
2020
Q4 		$4.08M Buy
16,643
+1,694
+11% +$437K 0.09% 192
2020
Q3 		$4.24M Sell
14,949
-4,585
-23% -$1.28M 0.12% 151
2020
Q2 		$5.23M Buy
19,534
+12,629
+183% +$3.8M 0.17% 108
2020
Q1 		$2.18M Sell
6,905
-8,022
-54% -$2.43M 0.08% 247
2019
Q4 		$4.43M Buy
+14,927
New +$4.14M 0.14% 163

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's BIIB Position: Q1 2026 in Review

Banco Bilbao Vizcaya Argentaria reduced its Biogen (BIIB) stake by 71% in Q1 2026, selling an estimated $19.3M and leaving 42,471 shares worth $7.77M. The position accounts for 0.05% of the portfolio, ranked #227.

Banco Bilbao Vizcaya Argentaria first reported a position in BIIB in Q4 2019 and has held it in 26 quarters since. The position peaked at $42.6M in Q2 2023. 1,004 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Banco Bilbao Vizcaya Argentaria held 42,471 shares of Biogen worth $7.77M as of Q1 2026.
  • Banco Bilbao Vizcaya Argentaria sold 104,480 Biogen shares in Q1 2026, an estimated $19.3M.
  • Biogen made up 0.05% of Banco Bilbao Vizcaya Argentaria's portfolio in Q1 2026, its #227 holding.
  • Banco Bilbao Vizcaya Argentaria first reported a position in Biogen in Q4 2019 and has held it in 26 quarters since.
  • Banco Bilbao Vizcaya Argentaria's Biogen position peaked at $42.6M in Q2 2023.
  • 1,004 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q1 2026, filed 14 May 2026.